Combination antiretroviral therapy (ART) suppresses human immunodeficiency virus (HIV)
replication and improves immune function, but is unable to eradicate the virus. Therefore …

HIV infection alters the natural history of several cancers, in large part due to its effect on the
immune system. Immune function in people living with HIV may vary from normal to highly …

Abstract According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), as of
2019, approximately 42.2 million people have died from acquired immunodeficiency …

Detection of residual plasma viremia in antiretroviral therapy (ART)-suppressed HIV-infected
individuals is critical for characterizing the latent reservoir and evaluating the impact of cure …

Introduction: Hodgkin lymphoma (HL) can occur in different host conditions, ie in the general
population and immunocompromised individuals, either during HIV infection or solid …

Background Identification of nonviral markers of human immunodeficiency virus (HIV)
infection that increase before viral rebound during analytical treatment interruption (ATI) may …

Oral administration of a combination of two or three antiretroviral drugs (cART) has
transformed HIV from a life-threatening disease to a manageable infection. However, as the …

El linfoma de Hodgkin (LH) se debe a la transformación clonal de células originadas en los
linfocitos B, lo que genera las células binucleadas patognomónicas de Reed-Sternberg. El …

Objectives The aim of this study was to assess soluble CD30 (sCD30), a protein that
colocalises with HIV-1 RNA and DNA in lymphoid cells and tissues, in cerebrospinal fluid …

Although the incidence of non-Hodgkin lymphoma appears to be substantially decreasing in
people living with HIV, growing evidence suggests that the ageadjusted incidence of …